{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:21:31Z","timestamp":1790749291689,"version":"4.1.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00571","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T06:41:46Z","timestamp":1594104106000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Daniel","family":"Zielonka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Stawinska-Witoszynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.nmd.2015.08.004","article-title":"Low D4Z4 copy number and gender difference in Korean patients with facioscapulohumeral muscular dystrophy type 1","volume":"25","author":"Park","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1093\/brain\/awt226","article-title":"Large scale genotype-phenotypeanalyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy","volume":"136","author":"Ricci","year":"2013","journal-title":"Brain."},{"key":"B3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.nmd.2011.11.001","article-title":"Mutation spectrum and phenotypic manifestation in FSHD Greek patients","volume":"22","author":"Sakellariou","year":"2012","journal-title":"Neuromuscul Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nmd.2003.07.001","article-title":"Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD)","volume":"14","author":"Tonini","year":"2004","journal-title":"Neuromuscul Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.0.CO;2-R","article-title":"The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females","volume":"77","author":"Zatz","year":"1998","journal-title":"Am J Med Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10072-006-0722-8","article-title":"Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study","volume":"27","author":"Padua","year":"2006","journal-title":"Neurol Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1529-8027.2008.00159.x","article-title":"Correlation between clinical\/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A","volume":"13","author":"Padua","year":"2008","journal-title":"J Peripher Nerv Syst."},{"key":"B8","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1212\/01.wnl.0000176062.44360.49","article-title":"Quality of life in patients with Charcot-Marie-Tooth disease","volume":"65","author":"Vinci","year":"2005","journal-title":"Neurology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jns.2013.10.029","article-title":"Clinical spectrum and gender differences in a large cohort of Charcot-Marie-Tooth type 1A patients","volume":"336","author":"Colomban","year":"2014","journal-title":"J Neurol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF03401859","article-title":"Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients","volume":"7","author":"Schuurmans","year":"2001","journal-title":"Mol Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.numecd.2019.06.015","article-title":"Polyvascular subclinical atherosclerosis in familial hypercholesterolemia: the role of cholesterol burden and gender","volume":"29","author":"Mattina","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3988\/jcn.2018.14.2.153","article-title":"Attention deficit hyperactivity disorder in neurofibromatosis type 1: evaluation with a continuous performance test","volume":"14","author":"Cohen","year":"2018","journal-title":"J Clin Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1212\/WNL.0b013e31822e7ca0","article-title":"The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study","volume":"77","author":"Jacobi","year":"2011","journal-title":"Neurology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","article-title":"Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study","volume":"14","author":"Jacobi","year":"2015","journal-title":"Lancet Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/brain\/121.4.589","article-title":"The natural history of degenerative ataxia: a retrospective study in 466 patients","volume":"121","author":"Klockgether","year":"1998","journal-title":"Brain."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/mds.22627","article-title":"Progression of ataxia in patients with Machado-Joseph disease","volume":"24","author":"Fran\u00e7a","year":"2009","journal-title":"Mov Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jns.2016.10.029","article-title":"Episodic ataxia and SCA6 within the same family due to the D302N CACNA1A gene mutation","volume":"371","author":"Pradotto","year":"2016","journal-title":"J Neurol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12031-011-9596-1","article-title":"A novel mutation in CACNA1S gene associated with hypokalemic periodic paralysis which has a gender difference in the penetrance","volume":"46","author":"Li","year":"2012","journal-title":"J Mol Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0272-6386(00)70042-4","article-title":"Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease","volume":"35","author":"Ishikawa","year":"2000","journal-title":"Am J Kidney Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/ki.1995.319","article-title":"Gender-dependent disease severity in autosomal polycystic kidney disease of rats","volume":"48","author":"Gretz","year":"1995","journal-title":"Kidney Int."},{"key":"B21","first-page":"116","article-title":"Gender differences in the prevalence and severity of bone disease in thalassaemia","volume":"6","author":"Kyriakou","year":"2008","journal-title":"Pediatr Endocrinol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/hmg\/2.10.1535","article-title":"Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent","volume":"2","author":"Telenius","year":"1993","journal-title":"Hum Mol Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jmg.31.5.377","article-title":"Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset","volume":"31","author":"Trottier","year":"1994","journal-title":"J Med Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1399-0004.1995.tb03941.x","article-title":"Correlation between magnitude of CAG repeat length alterations and length of the paternal repeat in paternally inherited Huntington's disease","volume":"47","author":"N\u00f8rrem\u00f8lle","year":"1995","journal-title":"Clin Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ejmg.2011.04.002","article-title":"Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease","volume":"54","author":"Aziz","year":"2011","journal-title":"Eur J Med Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/humu.22637","article-title":"Instability of trinucleotidic repeats during chromatin remodeling in spermatids","volume":"35","author":"Simard","year":"2014","journal-title":"Hum Mutat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington's disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.410360412","article-title":"Trinucleotide repeat length and rate of progression of Huntington's disease","volume":"36","author":"Illarioshkin","year":"1994","journal-title":"Ann Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1212\/WNL.46.2.527","article-title":"Trinucleotide repeat length and clinical progression in Huntington's disease","volume":"46","author":"Brandt","year":"1996","journal-title":"Neurology."},{"key":"B31","first-page":"903","article-title":"Clinical picture of patients with Huntington's disease in relation to the number of trinucleotide CAG repeats in IT-15 gene","volume":"36","author":"Zielonka","year":"2002","journal-title":"Neurol Neurochir Pol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/archneur.1995.00540320021009","article-title":"Correlations between triplet repeat expansion and clinical features in Huntington's disease","volume":"52","author":"Claes","year":"1995","journal-title":"Arch Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1212\/WNL.44.6.1137","article-title":"CAG repeat size and clinical presentation in Huntington's disease","volume":"44","author":"Ashizawa","year":"1994","journal-title":"Neurology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/jmg.31.11.872","article-title":"Trinucleotide repeat length and progression of illness in Huntington's disease","volume":"31","author":"Kieburtz","year":"1994","journal-title":"J Med Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1212\/WNL.53.5.1000","article-title":"Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial","volume":"53","author":"Kremer","year":"1999","journal-title":"Neurology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","article-title":"The association of CAG repeat length with clinical progression in Huntington disease","volume":"66","author":"Rosenblatt","year":"2006","journal-title":"Neurology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/mds.21988","article-title":"The relationship between CAG repeat length and clinical progression in Huntington's disease","volume":"23","author":"Ravina","year":"2008","journal-title":"Mov Disord."},{"key":"B38","first-page":"688","article-title":"Gender differences in the CAG repeats and clinical picture correlations in Huntington's disease","volume":"71","author":"Zielonka","year":"2008","journal-title":"Ceska Slovenska Neurol Neurochirurg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","article-title":"The influence of gender on phenotype and disease progression in patients with Huntington's disease","volume":"19","author":"Zielonka","year":"2013","journal-title":"Parkinsonism Relat Disord."},{"key":"B40","first-page":"115","article-title":"Study protocol of registry e version 2.0-European Huntington's disease network (EHDN)","volume":"46","author":"Handley","year":"2011","journal-title":"Hygeia Public Health."},{"key":"B41","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in Huntington's disease","volume":"41","author":"Penney","year":"1997","journal-title":"Ann Neurol."},{"key":"B42","first-page":"1202","article-title":"The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size","volume":"60","author":"Brinkman","year":"1997","journal-title":"Am J Hum Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ajmg.a.20190","article-title":"Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease","author":"Djousse","year":"2003","journal-title":"Am J Med Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.parkreldis.2018.01.006","article-title":"The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease","volume":"49","author":"Zielonka","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"key":"B45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1212\/WNL.54.2.452","article-title":"Rate of functional decline in Huntington's disease","volume":"54","author":"Marder","year":"2000","journal-title":"Neurology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/mds.22953","article-title":"Cognitive and functional decline in Huntington's disease: dementia criteria revisited","volume":"25","author":"Peavy","year":"2010","journal-title":"Mov Disord."},{"key":"B47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.870080212","article-title":"Assessment of adaptive functioning in Huntington's disease","volume":"8","author":"Bylsma","year":"1993","journal-title":"Mov Disord."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1212\/01.WNL.0000086373.32347.16","article-title":"Huntington's disease: clinical correlates of disability and progression","volume":"61","author":"Mahant","year":"2003","journal-title":"Neurology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/mds.27653","article-title":"Huntington's disease in the United States: variation by demographic and socioeconomic factors","volume":"34","author":"Bruzelius","year":"2019","journal-title":"Mov Disord."},{"key":"B50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease","volume":"178","author":"Dorner","year":"2007","journal-title":"Behav Brain Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","article-title":"Sex differences in a transgenic rat model of Huntington's disease: decreased 17\u03b2-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males","volume":"17","author":"Bode","year":"2008","journal-title":"Hum Mol Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0147583","DOI":"10.1371\/journal.pone.0147583","article-title":"Sex differences in circadian dysfunction in the BACHD mouse model of Huntington\u201ds disease","volume":"11","author":"Kuljis","year":"2016","journal-title":"PLoS One."},{"key":"B53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.niox.2018.12.002","article-title":"Age- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease","volume":"83","author":"Padovan-Neto","year":"2019","journal-title":"Nitric Oxide."},{"key":"B54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fmed.2020.00079","article-title":"Prevalence of non-psychiatric comorbidities in pre-symptomatic and symptomatic Huntington's disease gene carriers in Poland","volume":"7","author":"Zielonka","year":"2020","journal-title":"Front Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1002\/cpns.47","article-title":"Overview of Huntington's disease models: neuropathological, molecular, behavioral differences","volume":"83","author":"Rangel-Barajas","year":"2018","journal-title":"Curr Protoc Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ana.20428","article-title":"Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia","volume":"57","author":"Markianos","year":"2005","journal-title":"Ann Neurol."},{"key":"B57","first-page":"199","article-title":"Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington's disease","volume":"28","author":"Markianos","year":"2007","journal-title":"Neuro Endocrinol Lett."},{"key":"B58","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/jnr.23980","article-title":"Sex-specific effects of the Huntington gene on normal neurodevelopment","volume":"95","author":"Lee","year":"2017","journal-title":"J Neurosci Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41582-019-0294-x","article-title":"Sex differences in movement disorders","volume":"16","author":"Meoni","year":"2020","journal-title":"Nat Rev Neurol."},{"key":"B60","first-page":"107","article-title":"Estrogen and Parkinson's disease","volume":"91","author":"Horstink","year":"2003","journal-title":"Adv Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/mds.870010112","article-title":"Menstrual- related fluctuations in Parkinson's disease","volume":"1","author":"Quinn","year":"1986","journal-title":"Mov Disord."},{"key":"B62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/00207458908986223","article-title":"Estrogens and the pathophysiology of Parkinson's disease","volume":"45","author":"Sandyk","year":"1989","journal-title":"Int J Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4065\/75.3.235","article-title":"Effect of hormone variations and other factors on symptom severity in women with dystonia","volume":"75","author":"Gwinn-Hardy","year":"2000","journal-title":"Mayo Clin Proc."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1212\/WNL.54.12.2292","article-title":"Estrogen improves motor disability in Parkinsonian postmenopausal women with motor fluctuations","volume":"54","author":"Tsang","year":"2000","journal-title":"Neurology."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00571\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T06:41:54Z","timestamp":1594104114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00571\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":64,"alternative-id":["10.3389\/fneur.2020.00571"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00571","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"article-number":"571"}}